Feb. 1, 2010 -- The Federation of American Societies for Experimental Biology has launched a new series, Horizons in Bioscience, to provide educational, one-page articles that highlight cutting-edge scientific research on the brink of clinical application and describe the pathway of discovery. The first in the new series, “How Biomedical Research Provides Fertility Hope to Cancer Survivors,” discusses the latest findings in oncofertility.

Horizons in Bioscience is intended to supplement FASEB’s existing series, Breakthroughs in Bioscience, which comprises longer, illustrated articles documenting how basic research discoveries are translated into new therapies or medical technologies.

“Breakthroughs in Bioscience examines treatments currently in use by millions of patients and tells the stories of the science that underlie those clinical advancements,” said Carrie Wolinetz, FASEB’S Director of Scientific Affairs and Public Relations. “Horizons in Bioscience provides the opportunity to explore exciting areas of science in the very early stages of clinical research and use.”
 
FASEB has also recently released a new article in the Breakthroughs in Bioscience series, titled “Magic Bullets and Monoclonals: An Antibody Tale.”